Atypical journalists probe Gurmit Singhs speeding scandal, insecurities on The Assembly
| LIANDelisted Stock | USD 2.18 0.05 2.24% |
About 61% of LianBio ADR's investor base is looking to short. The analysis of current outlook of investing in LianBio ADR suggests that many traders are alarmed regarding LianBio ADR's prospects. LianBio ADR's investing sentiment overview a quick insight into current market opportunities from investing in LianBio ADR. Many technical investors use LianBio ADR stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
LianBio |
What happens when a group of neurodivergent individuals get to quiz big names like Gurmit Singh and President Tharman The Assembly brings open conversations to the forefront, in a format that is the first of its kind in Asia.
Read at channelnewsasia.com
 |
LianBio ADR Fundamental Analysis
We analyze LianBio ADR's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of LianBio ADR using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of LianBio ADR based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Retained Earnings
Retained Earnings Comparative Analysis
LianBio ADR is currently under evaluation in retained earnings category among its peers. Retained Earnings is a balance sheet account that refers to the portion of company income that is retained by the firm. In other words, it is a part of earnings that is not paid out as dividends or otherwise distributed to owners. Retained Earnings are calculated by adding net income to last period retained earnings and subtracting any dividends paid to owners.
LianBio ADR Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LianBio ADR stock to make a market-neutral strategy. Peer analysis of LianBio ADR could also be used in its relative valuation, which is a method of valuing LianBio ADR by comparing valuation metrics with similar companies.
Peers
LianBio ADR Related Equities
| VRCA | Verrica Pharmaceuticals | 6.25 | ||||
| LRMR | Larimar Therapeutics | 2.77 | ||||
| NXTC | NextCure | 2.60 | ||||
| ABOS | Acumen Pharmaceuticals | 2.48 | ||||
| SNSE | Sensei Biotherapeutics | 1.89 | ||||
| DAWN | Day One | 1.13 | ||||
| HOOK | Hookipa Pharma | 0.52 | ||||
| ASMB | Assembly Biosciences | 0.49 | ||||
| ELDN | Eledon Pharmaceuticals | 0.25 | ||||
| ACHL | Achilles Therapeutics | 0.87 | ||||
| NUVB | Nuvation Bio | 1.18 | ||||
| INZY | Inozyme Pharma | 1.45 | ||||
| TERN | Terns Pharmaceuticals | 1.56 | ||||
| FENC | Fennec Pharmaceuticals | 1.60 | ||||
| TIL | Instil Bio | 2.10 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in LianBio Stock
If you are still planning to invest in LianBio ADR check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LianBio ADR's history and understand the potential risks before investing.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world |